CalciMedica, Inc. is a clinical-stage biopharmaceutical company developing therapeutics targeting calcium release-activated calcium (CRAC) channels for serious inflammatory, immunologic, and cellular injury conditions. Its lead candidate, Auxora (zegocractin), is an IV small-molecule CRAC channel inhibitor evaluated in Phase 2 trials for acute pancreatitis, severe COVID-19 pneumonia, pediatric asparaginase-induced pancreatic toxicity, and acute kidney injury. The company is also developing CM5480 for pulmonary arterial hypertension, with an IND submission anticipated in 2027.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2025-12-31 | 0001193125-26-088147 | EDGAR | 102K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046035 | EDGAR | 104K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038064 | EDGAR | 104K words |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006795 | EDGAR | 82K words |
| 2022-03-11 | 2021-12-31 | 0001564590-22-009728 | EDGAR | — |
| 2021-03-05 | 2020-12-31 | 0001564590-21-011305 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-344689 | EDGAR | 75K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277617 | EDGAR | 72K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107334 | EDGAR | 71K words |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071421 | EDGAR | 67K words |
| 2024-11-13 | 2024-09-30 | 0000950170-24-126296 | EDGAR | 70K words |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095490 | EDGAR | 69K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058744 | EDGAR | 66K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062176 | EDGAR | 70K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041844 | EDGAR | 68K words |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021775 | EDGAR | 68K words |
| 2022-11-10 | 2022-09-30 | 0001564590-22-037397 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001564590-22-029174 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-16 | 0001193125-26-393034 | EDGAR | 1K words |
| 2026-09-02 | 0001193125-26-379419 | EDGAR | 1K words |
| 2026-08-27 | 0001193125-26-369713 | EDGAR | 1K words |
| 2026-08-20 | 0001193125-26-357258 | EDGAR | 18K words |
| 2026-08-11 | 0001193125-26-343428 | EDGAR | 3K words |
| 2026-03-18 | 0001193125-26-114096 | EDGAR | 1K words |
| 2026-03-03 | 0001193125-26-086658 | EDGAR | 3K words |
| 2026-01-28 | 0001193125-26-027462 | EDGAR | 1K words |
| 2026-01-28 | 0001193125-26-025649 | EDGAR | 1K words |
| 2025-11-12 | 0001193125-25-275888 | EDGAR | 3K words |
110 total filings indexed. 82 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001534133 |
| Ticker | CALC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.calcimedica.com |
| Listed | 2020-09-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CALC (~200 tokens, structured JSON with cryptographic provenance)